Drug news and therapeutic news.

This talk describes common features of zombie trials using various examples including a detailed case study about Artemisia tea infusions in the treatment of Malaria [2]. B ACT-001 b B New JAK inhibitor safety data in 2023 b P. Vergne Salle SP 1 sp and T. Loupret SP 2 sp SP 1 sp I CHU de Limoges Equipe Pereine UR 22722, Limoges, France; i SP 2 sp I CHU de Limoges, Limoges, France i B Explain what has changed the practice: b JAK inhibitors represent a new treatment group, synthetic targeted therapies, whose efficacy has been demonstrated in numerous indications: rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, juvenile arthritis, atopic dermatitis, alopecia areata, and ulcerative colitis. But could the fact of thinking about the treatment on a daily basis be a key factor leading the patients to be more involved in the care? Safety data in patients having rheumatoid arthritis based on observational studies are available. [Extracted from the article]